155 related articles for article (PubMed ID: 14550847)
1. Genetic and pharmacological aspects of histamine H3 receptor heterogeneity.
Hancock AA; Esbenshade TA; Krueger KM; Yao BB
Life Sci; 2003 Oct; 73(24):3043-72. PubMed ID: 14550847
[TBL] [Abstract][Full Text] [Related]
2. Molecular pharmacological aspects of histamine receptors.
Leurs R; Smit MJ; Timmerman H
Pharmacol Ther; 1995 Jun; 66(3):413-63. PubMed ID: 7494855
[TBL] [Abstract][Full Text] [Related]
3. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
[TBL] [Abstract][Full Text] [Related]
4. Molecular and pharmacological characterization of the mouse histamine H3 receptor.
Chen J; Liu C; Lovenberg TW
Eur J Pharmacol; 2003 Apr; 467(1-3):57-65. PubMed ID: 12706455
[TBL] [Abstract][Full Text] [Related]
5. [The histamine H(3) receptor: a target for new drugs].
Arrang JM
Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
[TBL] [Abstract][Full Text] [Related]
6. Cloning and pharmacological characterization of the monkey histamine H3 receptor.
Yao BB; Sharma R; Cassar S; Esbenshade TA; Hancock AA
Eur J Pharmacol; 2003 Dec; 482(1-3):49-60. PubMed ID: 14660004
[TBL] [Abstract][Full Text] [Related]
7. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
[TBL] [Abstract][Full Text] [Related]
8. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
[TBL] [Abstract][Full Text] [Related]
9. Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H (3) receptor isoforms.
Esbenshade TA; Krueger KM; Yao BB; Witte DG; Estvander BR; Baranowski JL; Miller TR; Hancock AA
Inflamm Res; 2006 Apr; 55 Suppl 1():S45-6. PubMed ID: 16705378
[No Abstract] [Full Text] [Related]
10. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
11. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and pharmacological analysis of species-related histamine H(3) receptor heterogeneity.
Yao BB; Hutchins CW; Carr TL; Cassar S; Masters JN; Bennani YL; Esbenshade TA; Hancock AA
Neuropharmacology; 2003 May; 44(6):773-86. PubMed ID: 12681376
[TBL] [Abstract][Full Text] [Related]
13. (Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.
Sasse A; Stark H; Ligneau X; Elz S; Reidemeister S; Ganellin CR; Schwartz JC; Schunack W
Bioorg Med Chem; 2000 May; 8(5):1139-49. PubMed ID: 10882024
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of a new human histamine receptor, HH4R.
Nakamura T; Itadani H; Hidaka Y; Ohta M; Tanaka K
Biochem Biophys Res Commun; 2000 Dec; 279(2):615-20. PubMed ID: 11118334
[TBL] [Abstract][Full Text] [Related]
15. [The roles of histamine H3 receptors in the behavioral disorders and neuropsychopharmacological aspects of its ligands in the brain].
Onodera K; Miyazaki S
Nihon Yakurigaku Zasshi; 1999 Aug; 114(2):89-106. PubMed ID: 10511950
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on cognitive domains, H3 receptor ligands and neurological disease.
Hancock AA; Fox GB
Expert Opin Investig Drugs; 2004 Oct; 13(10):1237-48. PubMed ID: 15461554
[TBL] [Abstract][Full Text] [Related]
17. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
19. Identification and pharmacological characterization of the histamine H3 receptor in cultured rat astrocytes.
Mele T; Jurič DM
Eur J Pharmacol; 2013 Nov; 720(1-3):198-204. PubMed ID: 24432407
[TBL] [Abstract][Full Text] [Related]
20. Histamine H3-receptor isoforms.
Bakker RA
Inflamm Res; 2004 Oct; 53(10):509-16. PubMed ID: 15597144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
